Evaluation of the tolerability and efficacy of Sativex in multiple sclerosis.
about
Evidence for the efficacy and effectiveness of THC-CBD oromucosal spray in symptom management of patients with spasticity due to multiple sclerosisNeural correlates of interactions between cannabidiol and Δ(9) -tetrahydrocannabinol in mice: implications for medical cannabis.Cannabinoids therapeutic use: what is our current understanding following the introduction of THC, THC:CBD oromucosal spray and others?Long-Term Effects of Repeated Cycles of Intrathecal Triamcinolone Acetonide on Spasticity in MS Patients.
P2860
Evaluation of the tolerability and efficacy of Sativex in multiple sclerosis.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
Evaluation of the tolerability and efficacy of Sativex in multiple sclerosis.
@en
type
label
Evaluation of the tolerability and efficacy of Sativex in multiple sclerosis.
@en
prefLabel
Evaluation of the tolerability and efficacy of Sativex in multiple sclerosis.
@en
P2860
P1476
Evaluation of the tolerability and efficacy of Sativex in multiple sclerosis
@en
P2093
Antonio Garcia-Merino
Antonio J Sanchez
P2860
P304
P356
10.1586/14737175.2014.971758
P577
2014-11-01T00:00:00Z